Health Care/Hospital
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
SYDNEY, Sept. 16, 2021 /PRNewswire/ -- SuperTrans Medical ("STM"), a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multi-drug resistant bacterial infections, has announced that the U.S. National Institutes of Health (NIH) will be supporting additional dev...
2021-09-16 08:45
2175
Charles Bodner Joins CSafe Global as Chief Financial Officer
CSafe Global has hired Charles Bodner as CFO following Patrick Schafer's promotion to CEO in 2020. DAYTON, Ohio, Sept. 16, 2021 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner h...
2021-09-16 06:25
2303
Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly Traded on the Nasdaq via Merger with Adrian Cheng's Artisan Acquisition Corp.
* Prenetics' mission is to disrupt and decentralise the healthcare industry with a global opportunity of overUS$1.3 trillion. * Prenetics' multi-product healthcare ecosystem strategy is driven by prevention focused genomic testing, rapid diagnostics for COVID-19 and infectious diseases, and c...
2021-09-16 06:00
6562
Onyx Acclaimed by Frost & Sullivan for Facilitating Health Data Interoperability with Its SAFHIR Platform
Onyx's SAFHIR makes data systems compliant with federal regulations and enables the future of health data sharing SANTA CLARA, Calif., Sept. 15, 2021 /PRNewswire/ -- Based on its recent analysis of the North American healthcare data interoperability market,Frost & Sullivan recognizes Onyx Health...
2021-09-15 21:00
1674
Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform
CLEVELAND and LONDON, Sept. 15, 2021 /PRNewswire/ -- Within3's hybrid engagement platform is proven to increase the volume, quality, and value of insights generated by life science innovators, their key opinion leaders, patients, and other stakeholders. That's why multidisciplinary teams in the ...
2021-09-15 20:48
2105
Top Organizations Honored with Frost & Sullivan Asia-Pacific Best Practices Awards
In celebration of the award recipients, the second edition of Frost & Sullivan's 2021 Asia-Pacific Best Practices Virtual Awards Ceremony will be broadcasted live onSeptember 22, 2021, at 6:00 p.m. (GMT +8). SINGAPORE, Sept. 15, 2021 /PRNewswire/ -- Frost & Sullivan Best Practices Awards honor 2...
2021-09-15 20:34
1889
ThinkSono DVT detection software results are published in Nature digital medicine (npj)
LONDON and POTSDAM, Germany, Sept. 15, 2021 /PRNewswire/ -- A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, pot...
2021-09-15 19:34
1954
2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19
LONDON, Sept. 15, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of the2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook. The 2021 CMR ...
2021-09-15 16:00
1388
Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus
MOSCOW, Sept. 15, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of theRepublic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campai...
2021-09-15 16:00
1454
iGene Laboratory donates 25,000 SARS-CoV-2 PCR Kits to Indonesia
SINGAPORE, Sept. 15, 2021 /PRNewswire/ -- iGene Laboratory Pte. Ltd donates 25,000 SARS-CoV-2 PCR Kits toIndonesia to assist the government of the Republic ofIndonesia in managing the COVID-19 disease outbreak. The occasion was marked with a symbolic hand-over ceremony at the Republic of Indonesi...
2021-09-15 10:22
1906
CStone received China NMPA IND approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody, marking further expansion of its Pipeline 2.0
SUZHOU, China, Sept. 15, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigational ne...
2021-09-15 08:30
2265
Humanforce Releases Solution to Help Employers Manage COVID-19 Vaccination Policies
SYDNEY, Sept. 15, 2021 /PRNewswire/ -- As increasing vaccination rates become a primary path towards reopeningAustralia, local workers are indicating a preference to work in environments where their colleagues are vaccinated. To assist businesses in managing complex workplace vaccination issues,H...
2021-09-15 07:00
1809
Point-of-Care Ultrasound World Conference - September 17-18, 2021 Hosted by the Point-of-Care Ultrasound Certification Academy
Medical professionals from around the world gather to help define point-of-care ultrasound standards ROCKVILLE, Md., Sept. 14, 2021 /PRNewswire/ -- The global point-of-care ultrasound (POCUS) community of physicians, researchers and healthcare providers, will gather virtually at the2021 POCUS Wo...
2021-09-14 21:01
1284
PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever
HONG KONG, Sept. 14, 2021 /PRNewswire/ -- Researchers at The Hong Kong Polytechnic University (PolyU) have developed a groundbreaking, imaging-guided nanoparticle photothermal treatment for osteoarthritis pain, utilising the concept of targeted cancer therapy but instead applied to the protein th...
2021-09-14 20:37
1692
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs
VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...
2021-09-14 15:00
4975
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002
SHANGHAI, Sept. 14, 2021 /PRNewswire/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-center, rand...
2021-09-14 11:43
2394
Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts
New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals SEATTLE, Sept. 14, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation today launched it...
2021-09-14 11:00
2338
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
FREIBURG, Germany, Sept. 14, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-a...
2021-09-14 10:30
1641
CStone presents updated data from registrational clinical study of sugemalimab in patients with stage IV NSCLC in an oral presentation at IASLC 2021 WCLC
* Data with the longer follow-up showed that sugemalimab plus chemotherapy continued to demonstrate improvement in progression-free survival (PFS), after the primary efficacy endpoint was met at an interim PFS analysis last year * The updated data showed that the risk of disease progression or...
2021-09-14 08:30
2959
Meatable Enters into Joint Development Agreement with Royal DSM to Develop Affordable Growth Media for Cultivated Meat
AMSTERDAM, Sept. 14, 2021 /PRNewswire/ -- Meatable
2021-09-14 08:00
2214
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2928
